231 related articles for article (PubMed ID: 32728390)
21. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk.
Areia M; Spaander MC; Kuipers EJ; Dinis-Ribeiro M
United European Gastroenterol J; 2018 Mar; 6(2):192-202. PubMed ID: 29511549
[TBL] [Abstract][Full Text] [Related]
23. Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.
Qin S; Wang X; Li S; Tan C; Zeng X; Luo X; Yi L; Peng L; Wu M; Peng Y; Wang L; Wan X
Pharmacoeconomics; 2022 Jul; 40(7):725-737. PubMed ID: 35701687
[TBL] [Abstract][Full Text] [Related]
24. Screening and surveillance for gastric cancer in the United States: Is it needed?
Kim GH; Liang PS; Bang SJ; Hwang JH
Gastrointest Endosc; 2016 Jul; 84(1):18-28. PubMed ID: 26940296
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of prevention and early detection of gastric cancer in Western countries.
Lansdorp-Vogelaar I; Meester RGS; Laszkowska M; Escudero FA; Ward ZJ; Yeh JM
Best Pract Res Clin Gastroenterol; 2021; 50-51():101735. PubMed ID: 33975689
[TBL] [Abstract][Full Text] [Related]
26. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
27. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.
Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ
Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
29. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
30. Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study.
Qin S; Wang X; Li S; Tan C; Zeng X; Wu M; Peng Y; Wang L; Wan X
Front Public Health; 2022; 10():955120. PubMed ID: 36033760
[TBL] [Abstract][Full Text] [Related]
31. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions.
Areia M; Dinis-Ribeiro M; Rocha Gonçalves F
Helicobacter; 2014 Dec; 19(6):425-36. PubMed ID: 25164596
[TBL] [Abstract][Full Text] [Related]
32. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.
Brazzelli M; Aucott L; Aceves-Martins M; Robertson C; Jacobsen E; Imamura M; Poobalan A; Manson P; Scotland G; Kaye C; Sawhney S; Boyers D
Health Technol Assess; 2022 Jan; 26(7):1-286. PubMed ID: 35115079
[TBL] [Abstract][Full Text] [Related]
34. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
35. A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?
Januszewicz W; Turkot MH; Malfertheiner P; Regula J
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765621
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
37. Controlling Gastric Cancer in a World of Heterogeneous Risk.
Huang RJ; Laszkowska M; In H; Hwang JH; Epplein M
Gastroenterology; 2023 Apr; 164(5):736-751. PubMed ID: 36706842
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]